Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Sarcoma 1Prostatic Neoplasms 1Osteosarcoma 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 20enzalutamide 19apalutamide 17Prednisone 13Androgen Antagonists 13Abiraterone Acetate 13Specimen Handling 12abiraterone 8Radiotherapy 8Docetaxel 8Biopsy 8darolutamide 7Nivolumab 7cabazitaxel 6Radiosurgery 6Pluvicto 62-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 6Lutetium-177 5radium Ra 223 dichloride 4gallium 68 PSMA-11 4cabozantinib 4bicalutamide 4atezolizumab 4Surveys and Questionnaires 4Standard of Care 4Radiotherapy, Intensity-Modulated 4Radiation 4Lutetium 4pembrolizumab 3olaparib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Pafolacianine × 30 days × Clear all
NCT06434909 2026-06-01

CYTALUXâ„¢for the Intraoperative Imaging of Prostate Cancer

Indiana University

Phase 2 Completed
9 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡